We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

101 hedge funds and large institutions have $317M invested in ANI Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

469% more call options, than puts

Call options by funds: $672K | Put options by funds: $118K

258% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 12

147% more capital invested

Capital invested by funds: $128M → $317M (+$189M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

40% more funds holding

Funds holding: 72 → 101 (+29)

36% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 22

Holders
101
Holders Change
+29
Holders Change %
+40.28%
% of All Funds
2.69%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
43
Increased
30
Reduced
22
Closed
12
Calls
$672K
Puts
$118K
Net Calls
+$554K
Net Calls Change
+$554K

Top Buyers

1
CCM
Consonance Capital Management
New York
+$23.8M
2
State Street
State Street
Massachusetts
+$14.9M
3
PA
Perceptive Advisors
New York
+$13.8M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$9.81M
5
BIM
Bogle Investment Management
Massachusetts
+$8.56M

Top Sellers

1
DM
Deerfield Management
New York
-$17.2M
2
HVC
Healthcare Value Capital
New Jersey
-$9.9M
3
DCM
Driehaus Capital Management
Illinois
-$5.35M
4
PCM
Penn Capital Management
Pennsylvania
-$4.05M
5
TI
Turner Investments
Pennsylvania
-$4.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
1
Consonance Capital Management
New York
$61.5M +$23.8M +540,240 +98%
State Street
2
State Street
Massachusetts
$23.5M +$14.9M +338,278 +435%
Wells Fargo
3
Wells Fargo
California
$18.7M +$3.98M +90,258 +37%
BFA
4
BlackRock Fund Advisors
California
$18.2M +$6.97M +158,097 +96%
PA
5
Perceptive Advisors
New York
$17.6M +$13.8M +312,500 New
BIT
6
BlackRock Institutional Trust
California
$13.8M -$3.71M -84,214 -26%
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.8M +$77.8K +1,765 +0.8%
Allianz Asset Management
8
Allianz Asset Management
Germany
$12.7M +$9.81M +222,593 +6,956%
BIM
9
Bogle Investment Management
Massachusetts
$10.9M +$8.56M +194,128 New
FIM
10
Foresters Investment Management
New York
$10.5M +$432K +9,800 +6%
CM
11
Castleark Management
Illinois
$7.78M -$1.82M -41,394 -23%
TCM
12
Timpani Capital Management
Wisconsin
$6.08M +$1.85M +42,039 +64%
AQR Capital Management
13
AQR Capital Management
Connecticut
$6.03M +$551K +12,505 +13%
Morgan Stanley
14
Morgan Stanley
New York
$5.75M +$3.26M +73,999 +264%
MOACM
15
Mutual of America Capital Management
New York
$5.34M +$4.17M +94,628 New
ACM
16
Apex Capital Management
Ohio
$5.17M +$4.04M +91,692 New
RFC
17
Russell Frank Company
Washington
$4.22M +$991K +22,469 +43%
Northern Trust
18
Northern Trust
Illinois
$4.13M -$69K -1,564 -2%
TA
19
Teachers Advisors
New York
$4.05M +$2.75M +62,300 +651%
Renaissance Technologies
20
Renaissance Technologies
New York
$3.72M +$1.66M +37,600 +132%
EI
21
EAM Investors
California
$3.66M +$2.86M +64,941 New
Ameriprise
22
Ameriprise
Minnesota
$3.02M +$1.27M +28,860 +117%
UOC
23
UBS O'Connor
Illinois
$2.64M +$2.06M +46,773 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$2.63M +$450K +10,216 +28%
GCP
25
GSA Capital Partners
United Kingdom
$2.58M -$159K -3,600 -7%
1
2 3 4 5

ANIP Hedge Fund Activity: Q4 2014 in Review

101 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q4 2014, worth a combined $317M — up 147% from $128M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new ANIP positions and 12 closed out — a net gain of 31 holders — while 30 added to existing stakes and 22 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $23.8M. The largest seller was Deerfield Management, exiting entirely with an estimated $17.2M sold.

  • 101 institutional investors held ANI Pharmaceuticals (ANIP) as of Q4 2014, up from 72 in Q3 2014.
  • Funds reported $317M of ANI Pharmaceuticals stock for Q4 2014, up 147% quarter-over-quarter.
  • 43 funds opened new ANI Pharmaceuticals positions in Q4 2014 and 12 closed out, a net change of +31 holders.
  • The largest ANI Pharmaceuticals buyer in Q4 2014 was Consonance Capital Management, an estimated $23.8M added.
  • The largest ANI Pharmaceuticals seller in Q4 2014 was Deerfield Management, an estimated $17.2M sold.

Based on aggregated 13F filings for Q4 2014.